Diabetes mellitus and the risk for cardiovascular disease Joseph S. Alpert Editor’s Commentary Pages: 337 - 337
T-wave alternans for risk stratification and prevention of sudden cardiac death Etienne J. PruvotDavid S. Rosenbaum OriginalPaper Pages: 350 - 357
Evolving concepts in the treatment of atrial fibrillation Parimal B. ManiarJonathan S. Steinberg OriginalPaper Pages: 358 - 363
Catheter ablation of ventricular tachycardia in patients with ischemic heart disease Kyoko SoejimaWilliam G. Stevenson OriginalPaper Pages: 364 - 368
The DAVID trial and its implications: Where do we go from here? Brian Olshansky Clinical Trials Report Pages: 377 - 379
Pharmacologic management of atrial fibrillation in the elderly: Rate control, rhythm control, and anticoagulation Seth McClennenPeter J. Zimetbaum OriginalPaper Pages: 380 - 386
Advances in the acute pharmacologic management of cardiac arrhythmias Andrea SarkozyPaul Dorian OriginalPaper Pages: 387 - 394
Herbal medicine: Beneficial effects, side effects, and promising new research in the treatment of arrhythmias C. William StoutJonathan WeinstockMark S. Link OriginalPaper Pages: 395 - 401
Treatment of postural orthostatic tachycardia syndrome and inappropriate sinus tachycardia M. Yousuf KanjwalDaniel J. KosinskiBlair P. Grubb OriginalPaper Pages: 402 - 406
Advances in ablation therapy for complex arrhythmias: Atrial fibrillation and ventricular tachycardia David LinFrancis E. Marchlinski OriginalPaper Pages: 407 - 414